Abstract

Objective To evaluate the efficacy and safety of Yushen Tongluo Granule (YSTLG) combined with clomiphene citrate (CC) in the treatment of anovulatory infertility. Methods This randomized, double-blinded, placebo-controlled clinical trial was carried out in the Department of Obstetrics and Gynecology and the Department of Traditional Chinese Medicine (TCM). During the 3 menstrual cycle intervention periods, all subjects received 50 mg/day CC from day 5 until day 9 of the menstruation. If no ovulation, the amount of CC per cycle increased 50 mg/day until 150 mg/day. Participants in the experimental group received YSTLG, while participants in the control group received YSTLG placebo. The granules were orally taken from the end of menstruation until ovulation. When one leading follicle attained a diameter of 18 mm or more, 5000 U human chorionic gonadotropin (hCG) was given intramuscularly. The primary outcome measure was the ovulation rate, and follicular development was monitored by transvaginal ultrasound on the 10th day of the cycles until ovulation. Secondary outcome measures including the overall curative effect, endometrial thickness, and pregnancy outcomes were also compared between the two groups. Results The ovulation rate in the experimental group was higher than that in the control group (P < 0.05). Compared with the control group, the overall curative effect of the experimental group was better than that of the control group (P < 0.05), and the endometrial thickness in the ovulation phase was significantly thicker than that in the control group (P < 0.01). There was no significant difference in pregnancy rate and miscarriage rate between the experimental group and control group (P > 0.05). Conclusion The combined YSTLG and CC used to treat anovulatory infertility can improve the ovulation rate without affecting endometrial thickness, which is efficacious and safe.

Highlights

  • Infertility is a group of reproductive disorders caused by a variety of causes

  • It is found that 85% of anovulation was led to hypothalamic-pituitary-ovarian axis disorders caused by polycystic ovary syndrome (PCOS), abnormal body mass index (BMI), and endocrine diseases [4]. erefore, restoring ovulation is an important link in the treatment of infertility

  • We speculated that Yushen Tongluo Granule (YSTLG) combined with clomiphene citrate (CC) in the treatment of anovulatory infertility may improve the ovulation rate without affecting the endometrial thickness during ovulation, so as to increase the pregnancy rate and reduce the abortion rate. erefore, the goal of this trial was to evaluate the efficacy and safety of YSTLG combined with CC in the treatment of anovulatory infertility in a randomized, doubleblind, placebo-controlled clinical trial

Read more

Summary

Objective

To evaluate the efficacy and safety of Yushen Tongluo Granule (YSTLG) combined with clomiphene citrate (CC) in the treatment of anovulatory infertility. Participants in the experimental group received YSTLG, while participants in the control group received YSTLG placebo. Secondary outcome measures including the overall curative effect, endometrial thickness, and pregnancy outcomes were compared between the two groups. E ovulation rate in the experimental group was higher than that in the control group (P < 0.05). Compared with the control group, the overall curative effect of the experimental group was better than that of the control group (P < 0.05), and the endometrial thickness in the ovulation phase was significantly thicker than that in the control group (P < 0.01). Ere was no significant difference in pregnancy rate and miscarriage rate between the experimental group and control group (P > 0.05). E combined YSTLG and CC used to treat anovulatory infertility can improve the ovulation rate without affecting endometrial thickness, which is efficacious and safe Conclusion. e combined YSTLG and CC used to treat anovulatory infertility can improve the ovulation rate without affecting endometrial thickness, which is efficacious and safe

Introduction
Methods
Diagnostic Criteria
Outcomes
Results
Secondary Outcome Measures
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call